New drug targets tough pancreatic cancer in early trial
Disease control
Recruiting now
This study tests an experimental drug called BT5528 in adults with metastatic pancreatic cancer that has worsened after one prior treatment. The drug targets a specific protein on cancer cells. The goal is to see if it can shrink tumors and to check for side effects. All 39 parti…
Phase: PHASE2 • Sponsor: BicycleTx Limited • Aim: Disease control
Last updated May 13, 2026 16:01 UTC